Vaughan Nelson Investment Management L.P. Sells 657,560 Shares of The Chemours Company (NYSE:CC)

Vaughan Nelson Investment Management L.P. cut its holdings in The Chemours Company (NYSE:CC - Free Report) by 23.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,166,741 shares of the specialty chemicals company's stock after selling 657,560 shares during the period. Vaughan Nelson Investment Management L.P. owned approximately 1.45% of Chemours worth $44,028,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in CC. Marshall Wace LLP increased its holdings in shares of Chemours by 23.8% in the second quarter. Marshall Wace LLP now owns 7,009,868 shares of the specialty chemicals company's stock valued at $158,213,000 after purchasing an additional 1,347,710 shares in the last quarter. Khrom Capital Management LLC boosted its position in shares of Chemours by 54.6% during the second quarter. Khrom Capital Management LLC now owns 3,456,626 shares of the specialty chemicals company's stock worth $78,016,000 after purchasing an additional 1,220,967 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Chemours by 26.7% during the second quarter. American Century Companies Inc. now owns 1,811,957 shares of the specialty chemicals company's stock worth $40,896,000 after purchasing an additional 382,100 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Chemours by 1.4% during the second quarter. Bank of New York Mellon Corp now owns 1,606,453 shares of the specialty chemicals company's stock worth $36,258,000 after purchasing an additional 22,209 shares in the last quarter. Finally, Mackenzie Financial Corp raised its holdings in shares of Chemours by 16.4% during the second quarter. Mackenzie Financial Corp now owns 877,246 shares of the specialty chemicals company's stock worth $19,799,000 after acquiring an additional 123,418 shares during the period. Institutional investors own 76.26% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on CC shares. Morgan Stanley dropped their price objective on shares of Chemours from $30.00 to $25.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. Royal Bank of Canada cut their price objective on shares of Chemours from $28.00 to $25.00 and set an "outperform" rating for the company in a report on Wednesday, November 6th. UBS Group decreased their price target on shares of Chemours from $30.00 to $28.00 and set a "buy" rating for the company in a research report on Tuesday, August 6th. BMO Capital Markets upped their price target on shares of Chemours from $30.00 to $32.00 and gave the company an "outperform" rating in a research report on Monday, October 7th. Finally, Barclays upped their price target on shares of Chemours from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Tuesday, November 5th. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $24.88.

Chemours Stock Down 0.9 %

NYSE CC traded down $0.18 on Friday, hitting $18.89. 1,889,033 shares of the company were exchanged, compared to its average volume of 1,769,015. The company has a market cap of $2.82 billion, a PE ratio of 37.78 and a beta of 1.75. The Chemours Company has a 12 month low of $15.10 and a 12 month high of $32.70. The stock has a fifty day moving average of $19.12 and a 200-day moving average of $21.77. The company has a current ratio of 1.73, a quick ratio of 0.92 and a debt-to-equity ratio of 6.05.

Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.44 billion. Chemours had a net margin of 1.34% and a return on equity of 29.48%. Chemours's revenue was up .9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.64 earnings per share. As a group, analysts forecast that The Chemours Company will post 1.35 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.29%. The ex-dividend date of this dividend is Friday, November 15th. Chemours's dividend payout ratio (DPR) is 200.00%.

Insider Activity

In related news, SVP Alvenia Scarborough sold 7,500 shares of the firm's stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $20.64, for a total transaction of $154,800.00. Following the completion of the sale, the senior vice president now owns 16,645 shares in the company, valued at approximately $343,552.80. This trade represents a 31.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.47% of the stock is currently owned by corporate insiders.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.